Collegium Pharmaceutical, Inc. (COLL): Price and Financial Metrics

COLL POWR Grades

• COLL scores best on the Quality dimension, with a Quality rank ahead of 94.57% of US stocks.
• COLL's strongest trending metric is Growth; it's been moving down over the last 177 days.
• COLL ranks lowest in Momentum; there it ranks in the 9th percentile.

COLL Stock Summary

• The price/operating cash flow metric for COLLEGIUM PHARMACEUTICAL INC is higher than only 12.68% of stocks in our set with a positive cash flow.
• Over the past twelve months, COLL has reported earnings growth of -507.1%, putting it ahead of just 2.92% of US stocks in our set.
• Revenue growth over the past 12 months for COLLEGIUM PHARMACEUTICAL INC comes in at 71.27%, a number that bests 92.47% of the US stocks we're tracking.
• Stocks that are quantitatively similar to COLL, based on their financial statements, market capitalization, and price volatility, are XPOF, GHL, USIO, AMG, and PIPR.
• Visit COLL's SEC page to see the company's official filings. To visit the company's web site, go to www.collegiumpharma.com.

COLL Valuation Summary

• In comparison to the median Healthcare stock, COLL's price/sales ratio is 26.32% lower, now standing at 1.4.
• COLL's price/sales ratio has moved NA NA over the prior 102 months.

Below are key valuation metrics over time for COLL.

COLL Growth Metrics

Its 3 year net income to common stockholders growth rate is now at 241.79%.
• Its 4 year net income to common stockholders growth rate is now at 87.63%.
• The 3 year net cashflow from operations growth rate now stands at -56.03%.

COLL's revenue has moved up $64,974,000 over the prior 33 months.

The table below shows COLL's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	361.675	94.103	-42.837
2022-06-30	313.505	68.588	-35.248
2022-03-31	272.898	57.672	42.786
2021-12-31	276.868	103.557	71.517
2021-09-30	325.777	89.936	103.509
2021-06-30	326.11	106.862	106.749

COLL's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• COLL has a Quality Grade of B, ranking ahead of 83.9% of graded US stocks.
• COLL's asset turnover comes in at 0.493 -- ranking 87th of 681 Pharmaceutical Products stocks.
• IBIO, IRWD, and COCP are the stocks whose asset turnover ratios are most correlated with COLL.

The table below shows COLL's key quality metrics over time.